The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma
Jens Bedke, Laurence Albigès, Umberto Capitanio, Rachel Giles, Milan Hora, Börje Ljungberg, Lorenzo Marconi, Tobias Klatte, Alessandro Volpe, Yasmin Abu‐Ghanem, Saeed Dabestani, Sergio Fernandéz‐Pello, Fabian Hofmann, Teele Kuusk, Rana Tahbaz, Thomas Powles, Axel Bex
Topics & Concepts
MedicinePembrolizumabNivolumabAtezolizumabKidney cancerRenal cell carcinomaIpilimumabInternal medicineOncologyAdjuvantAdjuvant therapyImmunotherapyCancerRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers